Corporate ActionMay 26, 2026, 05:21 PM
Nanobiotix Closes Global Offering of ADSs, Shares, and Warrants
AI Summary
Nanobiotix S.A. announced the closing of its Global Offering, which included a U.S. Offering of American Depositary Shares (ADSs) and a European Offering of Ordinary Shares, alongside Pre-Funded Warrants. The company also confirmed the exercise of the U.S. Over-Allotment Option by the underwriters for additional ADSs. The offering is expected to close on or about May 26, 2026, raising capital for the company.
Key Highlights
- U.S. Offering of 225,373 American Depositary Shares (ADSs) at $38.98 per ADS.
- European Offering of 1,959,289 Ordinary Shares at 33.60 per Ordinary Share.
- Issuance of 345,099 Pre-Funded Warrants to purchase Ordinary Shares.
- Underwriters exercised option for an additional 33,805 ADSs at $38.98 per ADS.
- Pre-Funded Warrants are exercisable until May 26, 2036, with a remaining exercise price of 0.03 per share.
- Beneficial ownership limitation for warrants set at 9.99%, adjustable up to 19.99% (or 24.99% for voting rights).
Price Impact
More from NBTX